ResMed Backs FY27 Adjusted EPS of $12–$12.25
ResMed backed its FY27 adjusted EPS outlook at $12–$12.25.
Related stories
Alliant Energy Reports Q3 2026 EPS of $1.52 and 2027 Guidance
Alliant Energy reported third-quarter 2026 GAAP EPS of $1.52, up from $1.09 a year earlier. Nine-month EPS was $3.04, up 17% from $2.59; the company also provided 2027 guidance.
M impact | EARNINGS | Oct 30, 2026, 01:33 PM UTC
Imperial Oil reports higher Q3 net income; dividend unchanged
Imperial Oil reported higher net income for the third quarter and declared an unchanged quarterly dividend.
M impact | EARNINGS | Oct 30, 2026, 01:30 PM UTC
US stock futures fell for a second day as another batch of disappointing tech earnings fuelled the sector's selloff, with investors increasingly questioning the return on massive artificial intelligence spending as signs emerged that America's technology behemoths' core businesses are losing momentum. Crude oil rose.
US stock futures fell for a second day as another batch of disappointing tech earnings fuelled the sector's selloff, with investors increasingly questioning the return on massive a
H impact | EARNINGS | Oct 30, 2026, 01:16 PM UTC
Qualcomm Q4 2026 Earnings
H impact | EARNINGS | Oct 30, 2026, 01:15 PM UTC
AMD Q3 2026 Earnings
H impact | EARNINGS | Oct 30, 2026, 01:14 PM UTC
Apple Q4 2026 Earnings
H impact | EARNINGS | Oct 30, 2026, 01:12 PM UTC